Overview of age-variations
Age group comparisons |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
27036001 |
Age 29 ± 4, Gender ⚥ |
0.31 (CV (CV=SD of metabolite abundance (peak areas from LC-MS) divided by the mean)) |
LC/MS |
blood |
27036001 |
Age 81 ± 7, Gender ⚥ |
0.47 (CV (CV=SD of metabolite abundance (peak areas from LC-MS) divided by the mean)) |
LC/MS |
blood |
27374292 |
Age [25–35] (median=32), Gender ♂ (Japanese) |
1.312926 (average level of metabolite) |
UHPLC-MS/MS Negative mode |
serum |
27374292 |
Age [55–64] (median=60), Gender ♂ (Japanese) |
1.025356 (average level of metabolite) |
UHPLC-MS/MS Negative mode |
serum |
Linear regression |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
23838602 |
Age [17–85], Gender ⚥ |
-0.008 (β) |
UHPLC/MS/MS |
serum and plasma |
7835210 |
Age 51.2 ± 22, Gender ⚥ |
-0.296 (β) |
enzymatic method |
blood |
log2 ratio/log2(FC) |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |